Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia-Reference-Cited by-同舟云学术

Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia

Published:2018-10 Issue: Volume:277 Page:477-482
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Afanasieva Olga I.,Ezhov Marat V.^ORCID,Razova Oksana A.,Afanasieva Marina I.,Utkina Elena A.,Pokrovsky Sergei N.

Funder

IAS/Pfizer Independent Grant for Learning & Change

AstraZeneca

Amgen

Sanofi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation;Seidah;Proc. Natl. Acad. Sci. U.S.A.,2003

2. PCSK9 targets important for lipid metabolism;Schulz;Clin Res Cardiol Suppl,2017

3. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment;Maxwell;Proc. Natl. Acad. Sci. U.S.A.,2005

4. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia;Abifadel;Nat. Genet.,2003

5. PCSK9 Forum. PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era;Chapman;Curr. Opin. Lipidol.,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration?;Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense?;Journal of Clinical Medicine;2024-01-28

3. Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting;Biomedicines;2023-12-12

4. Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease;Diseases;2023-10-18

5. Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods;International Journal of Molecular Sciences;2023-09-09